ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Artificial intelligence in pancreatic cancer

Huang, Bowen; Huang, Haoran; Zhang, Shuting; Zhang, Dingyue; Shi, Qingya; Liu, Jianzhou; Guo, Junchao*清华大学; 中国医学科学院; 中国医学科学院北京协和医院
2022DOI: 10.7150/thno.77949
41被引5阅读
引用收藏
分享

摘要

Pancreatic cancer is the deadliest disease, with a five-year overall survival rate of just 11%. The pancreatic cancer patients diagnosed with early screening have a median overall survival of nearly ten years, compared with 1.5 years for those not diagnosed with early screening. Therefore, early diagnosis and early treatment of pancreatic cancer are particularly critical. However, as a rare disease, the general screening cost of pancreatic cancer is high, the accuracy of existing tumor markers is not enough, and the efficacy of treatment methods is not exact. In terms of early diagnosis, artificial intelligence technology can quickly locate high-risk groups through medical images, pathological examination, biomarkers, and other aspects, then screening pancreatic cancer lesions early. At the same time, the artificial intelligence algorithm can also be used to predict the survival time, recurrence risk, metastasis, and therapy response which could affect the prognosis. In addition, artificial intelligence is widely used in pancreatic cancer health records, estimating medical imaging parameters, developing computer-aided diagnosis systems, etc. Advances in AI applications for pancreatic cancer will require a concerted effort among clinicians, basic scientists, statisticians, and engineers. Although it has some limitations, it will play an essential role in overcoming pancreatic cancer in the foreseeable future due to its mighty computing power.

学科与关键词

关键词
Artificial intelligencemachine learningpancreatic cancerearly detectionprognosis prediction
相关
加载中…
  • Artificial intelligence for early detection of pancreatic adenocarcinoma: The future is promising
    Mendoza Ladd, Antonio; Diehl, David L.WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27(13): 1283-1295.被引 15
  • Application of artificial intelligence to pancreatic adenocarcinoma
    Chen, Xi; Fu, Ruibiao; Shao, Qian; Chen, Yan; Ye, Qinghuang; Li, Sheng; He, Xiongxiong; Zhu, Jinhui*Frontiers in Oncology, 2022, 12: 960056.被引 5
  • Deep Learning Applications in Pancreatic Cancer
    Patel, Hardik*; Zanos, Theodoros; Hewitt, D. BrockCancers, 2024, 16(2): 436.被引 3
查看全部 →

发表信息

论文状态
公开发表
发表日期
2022
卷期
第 12 卷, 第 16 期
页码
6931-6954
DOI
10.7150/thno.77949
语言
ENGLISH
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81972324]; CAMS Innovation Fund for Medical Sciences [2021-I2M-1-002]

作者

  • H

    Huang, Bowen (第一作者)

    tsinghua univ · chinese acad med sci · peking union med coll · peking union med coll hosp

  • H

    Huang, Haoran

    tsinghua univ · chinese acad med sci · peking union med coll · peking union med coll hosp

查看全部 7 位作者收起作者
  • Z

    Zhang, Shuting

    tsinghua univ · chinese acad med sci · peking union med coll · peking union med coll hosp

  • Z

    Zhang, Dingyue

    tsinghua univ · chinese acad med sci · peking union med coll · peking union med coll hosp

  • S

    Shi, Qingya

    tsinghua univ

  • L

    Liu, Jianzhou

    chinese acad med sci · peking union med coll · peking union med coll hosp

  • G

    Guo, Junchao (通讯)

    chinese acad med sci · peking union med coll · peking union med coll hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417